Journal articlePreclinical

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

Brain research, 2006 Oct 30. Dolotov OV, Karpenko EA, Inozemtseva LS and 11 others.

Study type

Journal article

Subjects

Animal / preclinical (no Humans MeSH term)

Journal

Brain research

Published

2006 Oct 30

PubMed

PMID 16996037 ↗

DOI

10.1016/j.brainres.2006.07.108 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Semax →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Administration, IntranasalAdrenocorticotropic HormoneAnimalsAvoidance LearningBody WeightBrain-Derived Neurotrophic FactorCognitionConditioning, PsychologicalDose-Response Relationship, DrugExonsHippocampusNootropic Agents

Other papers on Semax

Clinical trial · 2018

[The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

Journal article · 2001

[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page